An observational study in Cardiac Arrest, sponsored by Azienda Usl di Bologna. Recruiting at 1 site in Italy. Open to participants aged Up to 120 Years. Per ClinicalTrials.gov, last updated 2022-02-16.
Sponsored by Azienda Usl di Bologna · Observational
Evaluation of clinical, logistical, and technical factors (e.g. implementation of pre-arrival instructions, implementation of the DAE RespondER, mechanical chest compressor, REBOA, and E-CPR) that impact on the outcomes of out-of-hospital cardiac arrest patients.
966 studies on the registry are indexed under Heart Arrest; 227 are open to participants now.
This study's planned enrollment of 5,000 is above the median of 200 across 383 observational studies indexed under Heart Arrest.
Browse Heart Arrest studies →Azienda Usl di Bologna is the lead sponsor of 40 studies on the registry; 13 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Population served by EMS of Bologna area
Exclusion Criteria:
Out of hospital cardiac arrest patients (Historical cohort) from 1st January 2009 and 30th June 2020. Out of hospital cardiac arrest patients from 1st July 2020 and 31st December 2025.
Other: Observational study without specific intervention
Observational study with standard cardiac arrest approach
ROSC (Return of spontaneous circulation)
ROSC (Return of spontaneous circulation) of cardiac arrest patients
Time frame: 1st July 2020 to 31st December 2025
Hospital admission status
Hospital admission status of cardiac arrest patients
Time frame: 1st July 2020 to 31st December 2025
Hospital discharge status/survival at 30 days
Hospital discharge status/survival at 30 days of cardiac arrest patients
Time frame: 30 days
Survival at 6 months
Survival at 6 months of cardiac arrest patients
Time frame: 6 months
Survival at 1 years
Survival at 1 years of cardiac arrest patients
Time frame: 1 year
Plan to share: No
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Azienda Usl di Bologna